Skip to main content
SpringerLink
Log in

Reduzierte NOAK-Dosis bei Vorhofflimmern: Wirksamkeit und Sicherheit im Vergleich mit Warfarin

Reduced NOAK dose in atrial fibrillation: efficacy and safety compared with warfarin

  • Journal Club
  • Published:
Zeitschrift für Gerontologie und Geriatrie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomized trials. Lancet 383:955–962

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Altersmedizin, Klinikum Frankfurt Höchst, Gotenstraße 6–8, 65929, Frankfurt am Main, Deutschland

    Kerstin Amadori

Authors
  1. Kerstin Amadori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kerstin Amadori.

Ethics declarations

Interessenkonflikt

K. Amadori gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amadori, K. Reduzierte NOAK-Dosis bei Vorhofflimmern: Wirksamkeit und Sicherheit im Vergleich mit Warfarin. Z Gerontol Geriat 50, 639–640 (2017). https://doi.org/10.1007/s00391-017-1302-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00391-017-1302-7

Search

Navigation